Basit öğe kaydını göster

dc.contributor.authorTotan, M
dc.contributor.authorDagdemir, A
dc.contributor.authorMuslu, A
dc.contributor.authorAlbayrak, D
dc.date.accessioned2020-06-21T15:48:55Z
dc.date.available2020-06-21T15:48:55Z
dc.date.issued2002
dc.identifier.issn0803-5253
dc.identifier.urihttps://doi.org/10.1080/080352502753457978
dc.identifier.urihttps://hdl.handle.net/20.500.12712/22082
dc.descriptionWOS: 000173762500014en_US
dc.descriptionPubMed: 11883821en_US
dc.description.abstractBetween 1981 and 2001. we retrospectively analysed 40 cases of visceral leishmaniasis (VL) admitted to the Paediatric Infection Unit of Ondokuz Mayis University Hospital, in the middle Black Sea region of Turkey. Median age at presentation was 3 y. Fever and splenomegaly were found in all patients. Bone marrow smear examination resulted in the diagnosis of VL in 95% of cases. All patients were treated initially with meglumine antimonate and 95% of them were cured with this therapy. The remaining patients were cured with liposomal amphotericin B. Conclusions: VL should be considered in patients with fever and splenomegaly, particularly those residing in the Mediterranean region. Meglumine antimonate seems to be the first choice of treatment in childhood.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Asen_US
dc.relation.isversionof10.1080/080352502753457978en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectchildhooden_US
dc.subjectvisceral leishmaniasisen_US
dc.titleVisceral childhood leishmaniasis in Turkeyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume91en_US
dc.identifier.issue1en_US
dc.identifier.startpage62en_US
dc.identifier.endpage64en_US
dc.relation.journalActa Paediatricaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster